MANFREDI PAOLO L has a total of 11 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are Zelira Therapeutics Operations Pty Ltd, ADVICENNE and WASA MEDICALS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Manfredi Paolo L | 10 |
#2 | Inturrisi Charles E | 10 |
#3 | Manfredi Paolo | 1 |
#4 | Inturrisi Charles | 1 |
Publication | Filing date | Title |
---|---|---|
TW201912152A | Compounds for treatment or prevention of disorders of the nervous system and symptoms and manifestations thereof, and for cyto-protection against diseases and aging of cells, and symptoms and manifestations thereof | |
CN110573159A | D-methadone and derivatives thereof for the treatment of disorders of the nervous system | |
US2014088155A1 | d-Methadone for the treatment of psychiatric symptoms |